Innovative Preclinical Assessment Tools for Safety and Efficacy of Protein and Peptide Therapeutics … Of Peptides and P-ANDAS A Case Study of Taspoglutide by Annie De Groot | Sep 9, 2019EpiVax_PANDA_Taspoglutide_April_19_Final
Computational Identification of Self-Like Neoantigens Enables the Rapid Design of Immunogenic Cancer Vaccines by Annie De Groot | Apr 8, 2019EpiVax_Oncology_TRI-CON_CT26_04Mar19_32w44h
Promiscuous Coxiella burnetii CD4 Epitope Clusters Associated with Human Recall Responses are Candidates for Novel T-cell Targeted Multi-Epitope Q Fever Vaccine by Annie De Groot | Mar 29, 2019EpiVax_QVaxCelerate_NFID_28Mar19_PH2_56w42h
Structure-guided Immunogen Design: Modulating B cell and T cell Immunogenicity of First and Second Generation H7N9 Vaccines by Annie De Groot | Mar 20, 2019ACVR immune engineering poster 2019_20Mar2019_930am
Promiscuous Coxiella burnetii CD4 Epitope Clusters Associated With Human Recall Responses Are Candidates for a Novel T-Cell Targeted Multi-Epitope Q Fever Vaccine by Annie De Groot | Feb 15, 2019